Target intelligence / Profile preview

Transmembrane protein 62 (TMEM62)

Target
TMEM62
Molecular classification
Other, Transmembrane protein
01

Overview

Transmembrane protein 62 (TMEM62) is a protein-coding gene identified in Homo sapiens, with orthologs in mouse and other vertebrates[1][10][11]. TMEM62 encodes a multi-pass transmembrane protein, but its precise physiological role remains poorly understood. Bioinformatic predictions and gene ontology annotations suggest it may have hydrolase activity and can bind calcium ions, with some potential to bind lipids, carbohydrates, or proteins[1][2][8]. TMEM62 is broadly expressed across diverse tissues, including the brain, liver, kidney, and reproductive organs[7][9]. No direct connections to drug interaction, disease causality, or established biomarker utility have been supported in current literature or large biological databases[1][5][9][10]. TMEM62 is not classified as an established therapeutic target, nor is there evidence of involvement in canonical target classes such as G protein-coupled receptors, ion channels, or enzymes involved in well-defined metabolic pathways[1][10]. No data were found to suggest that TMEM62 is misspelled, not a genuine protein-coding gene, or a non-target—however, information about its function in human health or disease is notably sparse.

Other names
FLJ23375TMEM62transmembrane protein 62
02

Biological functions

hydrolase activitycalcium ion bindingpotentially carbohydrate derivative bindinglipid bindingenzyme regulator activityDNA bindingcytoskeletal protein binding
03

Disease associations

There is no direct, well-established disease role; minimal information is available regarding involvement in human disease

Beyond the preview

Go deeper on Transmembrane protein 62 (TMEM62).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 62 (TMEM62).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call